Global PEGylated Proteins Market to Reach US$ 2.8 Billion by 2032, Accelerated by Growing Prevalence of Chronic Diseases

May 26, 2023 | Healthcare

As per the latest report by IMARC Group, titled "PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032," the global PEGylated proteins market size reached US$ 1.3 Billion in 2023. PEGylation is the process of covalently attaching polyethylene glycol (PEG) molecules to proteins. It has revolutionized the field of therapeutic protein engineering and is extensively employed in the pharmaceutical industry. It offers numerous advantages, such as enhancing the properties and performance of therapeutic proteins. The production of PEGylated proteins involves chemically modifying the protein of interest with PEG chains, thereby altering its physicochemical properties. This modification imparts several beneficial characteristics, such as increased stability, reduced immunogenicity, prolonged half-life, and improved solubility, ultimately leading to improved therapeutic efficacy. One of its key benefits is the enhanced stability it provides to proteins, protecting them from degradation and denaturation. By shielding proteins from enzymatic degradation and immune recognition, PEGylation significantly extends their circulating half-life, allowing for less frequent dosing and improved patient compliance. Moreover, the attachment of PEG chains to proteins can reduce their immunogenicity, minimizing adverse immune reactions and increasing the safety profile of therapeutic interventions. In comparison to conventional protein-based therapeutics, PEGylated proteins demonstrate improved pharmacokinetic properties, resulting in optimized drug delivery and expanded therapeutic window. The reduced renal clearance and prolonged circulation time of PEGylated proteins enable targeted drug delivery to specific tissues or cells, enhancing efficacy while minimizing systemic toxicity. Currently, it has found application in various therapeutic areas, including oncology, immunology, and hematology. 

Global PEGylated Proteins Market Trends:

The global market for PEGylated proteins is primarily influenced by the growing prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, and the surging demand for targeted therapies. Moreover, the rising geriatric population has fueled the demand for innovative treatments, which is boosting the market growth. In confluence with this, significant advancements in biotechnology and protein engineering have led to the development of novel PEGylation techniques, enabling the modification of a wide range of proteins for various therapeutic applications, further propelling the market growth. Additionally, the increasing adoption of biologics, including PEGylated proteins, by healthcare providers and patients, the expanding research and development (R&D) activities in protein-based therapeutics, and the growing number of collaborations between pharmaceutical companies and academic institutions are contributing to the market growth. Apart from this, favorable regulatory environments and the increasing number of drug approvals for PEGylated protein-based therapies are creating a positive outlook for market growth. Besides this, the rising demand for personalized medicine and the escalating healthcare expenditure, coupled with the expanding biopharmaceutical industry, are fostering the market growth. In line with this, continuous technological advancements in drug delivery systems and the escalating focus on targeted drug delivery using PEGylated proteins are positively contributing to market growth. Other factors, such as the increasing awareness about the advantages of PEGylated proteins, including prolonged drug half-life, improved bioavailability, and reduced immunogenicity, and inflating consumer expenditure power, are accelerating the market growth. Looking forward, the market value is projected to reach US$ 2.8 Billion by 2032, expanding at a CAGR of 8.87% during 2024-2032.

Market Summary: 

  • By the product, the market is segmented into consumables (PEgylation reagents and PEgylation kits) and services. According to the report, consumables accounted for the largest market share.
  • Based on the protein type, the market is segregated into colony stimulating factors, interferons, erythropoietin, mAbs, recombinant factor VII, and others. According to the report, colony stimulating factors represented the largest segment.
  • On the basis of the application, the market is divided into cancer treatment, hepatitis, chronic kidney diseases, hemophilia, multiple sclerosis, gastrointestinal disorders, and others. According to the report, cancer treatment represented the largest segment.
  • Based on the end user, the market is categorized into pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes. According to the report, pharmaceutical and biotechnology companies represented the largest segment.
  • By the region, the market has been categorized into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. According to the report, North America was the largest market for PEGylated proteins.
  • The competitive landscape of the industry has also been examined with some of the key players being Abcam plc, Biomatrik Inc., Creative PEGWorks, Iris Biotech GmbH, JenKem Technology USA Inc., Laysan Bio Inc., NOF America Corporation (NOF Corporation), Profacgen, Thermo Fisher Scientific Inc., etc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Products Covered Consumables: PEGylation Reagents, PEGylation Kits
Protein Types Covered Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, Others
Applications Covered Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, Others
End Users Covered Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abcam plc, Biomatrik Inc., Creative PEGWorks, Iris Biotech GmbH, JenKem Technology USA Inc., Laysan Bio Inc., NOF America Corporation (NOF Corporation), Profacgen, Thermo Fisher Scientific Inc., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global PEGylated Proteins Market to Reach US$ 2.8 Billion by 2032, Accelerated by Growing Prevalence of Chronic Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More